Cigna (CI): Assessing Valuation Following Strong Q3 Results, 2026 Guidance, and Express Scripts Strategy Shift

Simply Wall St.

2025/11/02

Cigna Group (NYSE:CI) is drawing attention after announcing strong third-quarter earnings, an upbeat outlook for 2026, and a new approach for Express Scripts. These topics are on investors’ minds this...

网页链接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2580760684"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580760684\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580760684?lang=zh_TW&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/172899-main-header/1756254126085","is_english":true,"pubTime":"2025-11-02 01:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580760684","market":"hk","top_or_hot":-1,"title":"Cigna (CI): Assessing Valuation Following Strong Q3 Results, 2026 Guidance, and Express Scripts Strategy Shift","media":"Simply Wall St.","content":"<div>\n<p>Cigna Group (NYSE:CI) is drawing attention after announcing strong third-quarter earnings, an upbeat outlook for 2026, and a new approach for Express Scripts. These topics are on investors’ minds this...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/cigna-ci-assessing-valuation-following-strong-q3-results-202\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cigna (CI): Assessing Valuation Following Strong Q3 Results, 2026 Guidance, and Express Scripts Strategy Shift</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCigna (CI): Assessing Valuation Following Strong Q3 Results, 2026 Guidance, and Express Scripts Strategy Shift\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Simply Wall St.</strong><span class=\"h-time small\">2025-11-02 01:34</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>Cigna Group (NYSE:CI) is drawing attention after announcing strong third-quarter earnings, an upbeat outlook for 2026, and a new approach for Express Scripts. These topics are on investors’ minds this...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/cigna-ci-assessing-valuation-following-strong-q3-results-202\">网页链接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/cigna-ci-assessing-valuation-following-strong-q3-results-202\">Simply Wall St.</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B19Z3B42.SGD","symbol_name":"Legg Mason ClearBridge - Value A Acc SGD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/cigna-ci-assessing-valuation-following-strong-q3-results-202","article_id":"2580760684","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/172899-main-header/1756254126085"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/cigna-ci-assessing-valuation-following-strong-q3-results-202","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2580760684","pubTimestamp":1762018446,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Cigna Group (NYSE:CI) is drawing attention after announcing strong third-quarter earnings, an upbeat outlook for 2026, and a new approach for Express Scripts. These topics are on investors’ minds this week.\nSee our latest analysis for Cigna Group.\nDespite upbeat earnings and new strategic initiatives, Cigna Group’s share price return is down 19% over the past week and 16% over the last month, with the past year’s total shareholder return slipping more than 21%. While recent performance has...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","ESRX":"快捷药方","LU0058720904.USD":"联博国际健康护理基金A","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4588":"碎股","BK4196":"保健护理服务","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","CI":"信诺保险","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4585":"ETF&股票定投概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"translate_title":"Cigna(CI)：在强劲的第三季度业绩、2026年指引和Express Scripts战略转变后评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CI":1.5,"ESRX":1.5},"content_text":"Cigna Group (NYSE:CI) is drawing attention after announcing strong third-quarter earnings, an upbeat outlook for 2026, and a new approach for Express Scripts. These topics are on investors’ minds this week. See our latest analysis for Cigna Group. Despite upbeat earnings and new strategic initiatives, Cigna Group’s share price return is down 19% over the past week and 16% over the last month, with the past year’s total shareholder return slipping more than 21%. While recent performance has been challenging, the company’s longer-term return shows a more resilient picture, and this week’s announcements indicate efforts to reignite momentum. If you’re searching for other healthcare stocks showing strong fundamentals and fresh ideas, now’s an ideal moment to check out See the full list for free. With renewed earnings momentum, an improved revenue outlook, and analyst price targets well above current levels, investors are now weighing whether Cigna is undervalued or if the latest developments are already reflected in the share price. AdvertisementMost Popular Narrative: 30% Undervalued The widely followed narrative puts Cigna Group’s fair value nearly $100 per share above its last close. This sets a compelling contrast for investors considering the company’s recovery prospects.  Cigna is capitalizing on the growing demand for specialty pharmacy and care services, particularly as chronic diseases and complex treatments become more prevalent. The double-digit revenue growth in CuraScript and Accredo positions the company to capture an expanding portion of the high-growth $400B+ specialty space, supporting long-term revenue and earnings growth.  Read the complete narrative. What’s really fueling this large gap between market price and fair value? The narrative hinges on a series of bold forecasts about member growth, profit margins, and the future business mix. Want to peek at the numbers that shape this bullish scenario? Don’t miss the story behind these projections. You’ll want the full details before making your next move. Result: Fair Value of $349.04 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, persistent regulatory changes and overreliance on Evernorth's PBM business could challenge Cigna’s projected growth. This may lead to pressure on future earnings and margins. Find out about the key risks to this Cigna Group narrative.  Build Your Own Cigna Group Narrative If you see the story differently or want to dig into the numbers yourself, you can quickly craft your own detailed view in just a few minutes. Do it your way A great starting point for your Cigna Group research is our analysis highlighting 6 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? Don’t let opportunities slip by. Leverage Simply Wall Street’s powerful screener to pinpoint investments that match your interests and ambitions. Here are three angles you shouldn’t overlook:  Catch early movers by browsing these 3584 penny stocks with strong financials poised for strong financial performance and rapid growth before the crowd spots them. Maximize your yield by targeting these 22 dividend stocks with yields > 3% with robust payouts over 3%, which can help you build passive income streams. Ride the AI wave and find potential winners among these 26 AI penny stocks that are transforming industries with advanced intelligence and innovative applications.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}